Scarica l'app Stockscreener
3.48
1.42%
-0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
GoodRx (GDRX) Q2 2026 Earnings Call Transcript - AOL.com
GDRX Maintains Underweight Rating -- Price Target Raised to $4.0 - GuruFocus
Q2 2026 GoodRx Holdings, Inc. Earnings Call Transcript - GuruFocus
Justin Fengler Net Worth (2026) - GuruFocus
Big GoodRx (NASDAQ: GDRX) backer prepares share sale - Stock Titan
Technology Crossover Management X Ltd. Buys Shares of 1,653,566 GoodRx Holdings, Inc. $GDRX - MarketBeat
GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn
GoodRx Holdings Inc (GDRX) (Q2 2026) Earnings Call Highlights: R - GuruFocus
GoodRx (NASDAQ:GDRX) Rating Increased to Buy at Wall Street Zen - MarketBeat
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) - Yahoo Finance
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
GDRX Maintained by UBS -- Price Target Raised to $3.75 - GuruFocus
GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook - Yahoo Finance
GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise - Yahoo Finance
UBS Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $3.75 - Moomoo
GoodRx (NASDAQ:GDRX) Trading Down 5.1%What's Next? - MarketBeat
GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope (NASDAQ:GDRX) - Seeking Alpha
GDRX Maintained by Citigroup -- Price Target Raised to $5.00 - GuruFocus
GoodRx (NASDAQ:GDRX) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
GDRX Maintained by TD Cowen -- Price Target Raised to $5.00 - GuruFocus
GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook - finance.yahoo.com
GOODRX HOLDINGS, INC. : CITIGROUP RAISES TARGET PRICE TO $5 FROM $4 - Bitget
GDRX Maintains Overweight by Wells Fargo -- Price Target Raised to $5.00 - GuruFocus
GoodRx Holdings Price Target Raised to $5.00/Share From $3.50 by Wells Fargo - Moomoo
Prescription savings giant GoodRx could be opening office at The Pearl - The Business Journals
GoodRx Holdings Inc (GDRX) Stock Analysis & Forecast - TradingKey
GoodRx Holdings Inc (GDRX) Stock News Today - TradingKey
Wells Fargo & Company Boosts GoodRx (NASDAQ:GDRX) Price Target to $5.00 - MarketBeat
GoodRx Holdings Inc (GDRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GoodRx Holdings, Inc. Stock 12‑Month Price Target Raised to $3.7 - TradingView
Morgan Stanley Adjusts Price Target on GoodRx to $4 From $3, Maintains Equalweight Rating - marketscreener.com
Earnings call transcript: GoodRx lifts 2026 outlook after Q2 revenue beat - Investing.com Canada
GoodRx Holdings, Inc. Stock 12‑Month Price Target Raised to $3.55, Implies 9% Upside - TradingView
Transcript : GoodRx Holdings, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
GoodRx Lets Customers Shop Where They Want, CEO Says - marketscreener.com
GoodRx Q2 Earnings Call Highlights - MarketBeat
GoodRx (NASDAQ:GDRX) Stock Price Up 15.7%Here's Why - MarketBeat
GDRX: Pharma Direct and subscriptions drove Q2 outperformance, leading to raised 2026 guidance - TradingView
GoodRx Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
GDRX Looks 42.2% Undervalued on GF Value™ - GuruFocus
GDRX SWOT Analysis: Key Insights from the 10-Q Filing - GuruFocus
GoodRx (NASDAQ:GDRX) Posts Earnings Results, Hits Estimates - MarketBeat
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates - Yahoo Finance
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Tranche Update on GoodRx Holdings, Inc.'s Equity Buyback Plan announced on February 29, 2024. - marketscreener.com
Is GoodRx Holdings Inc (GDRX) Undervalued After Q2 Earnings? EPS - GuruFocus
GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars - Barchart.com
GoodRx Holdings, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Aug 05 (Reuters)GoodRx Holdings Q2 Revenue - Moomoo
GDRX: Pharma Direct and subscription growth drove raised 2026 guidance despite lower transactions - TradingView
GoodRx Holdings, Inc. (GDRX) Reports In-Line Q2 EPS; Offers Guidance - StreetInsider
GoodRx Reports Second Quarter 2026 Results - marketscreener.com
GoodRx Holdings, Inc. 2026: Revenue $200.41M, EPS $0.02— 10-Q Summary - TradingView
GoodRx Holdings (NASDAQ: GDRX) elevates Justin Fengler to CFO role - Stock Titan
GoodRx Holdings (NASDAQ: GDRX) pivots as Rx revenue falls 26% - Stock Titan
GoodRx Holdings, Inc. Announces Management Changes - marketscreener.com
GoodRx Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GoodRx (NASDAQ: GDRX) Q2 2026 revenue hits $200M as mix shifts - Stock Titan
0.03%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):